Insulin Resistance in Non-alcoholic Fatty Liver Disease

NCT01289639 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

11

Enrollment

FED

Sponsor class

Stopped Low recruitment in intervention study. Baseline data published.

Conditions

Fatty Liver

Interventions

DRUG: fenofibrate
DRUG: pioglitazone
DRUG: placebo

Sponsor

VA Office of Research and Development